RISK ORGAN DOSE REDUCTION OR TARGET DOSE ESCALATION WITH ISO-EFFECTIVE AND ISO-TOXIC ADAPTIVE RADIOTHERAPY FOR STAGE III NSCLC. (December 2022) - Hoppen, Lea; Kwok, Chung; Boda-Heggemann, Judit; Sarria, Gustavo R.; Willam, Marvin; Steil, Volker; Ehmann, Michael; Giordano, Frank; Fleckenstein, Jens